Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07458607 · ClinicalTrials.gov registry record · NA
UNC Tobacco Convenience Store
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- NA
- Development phase
- 1,185
- Enrollment target
NCT07458607: Recruiting NA study, sponsored by University of North Carolina, Chapel Hill.
NCT07458607 is a NA study that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 1,185 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07458607, a NA study, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,185 participants
- Enrollment target
Study Summary
The main purpose of this trial is to evaluate the impact of a menthol cigarette ban accompanied by a quit smoking campaign on tobacco purchasing behavior. Investigators will conduct a randomized clinical trial with \~1,185 US adults (ages 21+ years) who currently smoke menthol cigarettes.
Primary Outcome
Measured using purchase data for combustible tobacco products, defined as any cigarettes or little cigars and cigarillos. Response options are "No" (coded as 0) and "Yes" (coded as 1).
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Menthol ban + campaign
- BEHAVIORAL Menthol ban
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,185 participants |
| Start Date | 2026-04-20 |
| Est. Completion | 2028-04 |
| Phase | NA |
What NCT07458607 shows while recruiting
NCT07458607 is an interventional study that assigns participants to a tested intervention. Its 1,185 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% lower).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT07458607 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07458607 about?
NCT07458607 is a clinical study titled "UNC Tobacco Convenience Store". The main purpose of this trial is to evaluate the impact of a menthol cigarette ban accompanied by a quit smoking campaign on tobacco purchasing behavior. Investigators will conduct a randomized clinical trial with \~1,185 US adults (ages 21+ years) who currently smoke menthol cigarettes.
What is the current status of trial NCT07458607?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,185 participants. The study started on 2026-04-20. Estimated completion is 2028-04.
What interventions are being tested in trial NCT07458607?
The interventions under investigation include: Control (BEHAVIORAL), Menthol ban + campaign (BEHAVIORAL), Menthol ban (BEHAVIORAL).
Who is sponsoring clinical trial NCT07458607?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07458607's enrollment target sits among peer trials
1,185 89th of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT05580419 · 1,188 participants · NA
Impact of 4PCP on Practitioner and Patient Outcomes
- NCT06290869 · 1,188 participants · Phase 3
Tobacco Education and Lung Health Study (TEAL)
- NCT07286058 · 1,182 participants · Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI